Notably, although association of baseline expression levels of SDC1 and SDC4 with any agent did not reach statistical significance, we also observed a moderate association of pretreatment expression levels of SDC1 with log(IC50) of dasatinib ( r = −.450, FDR-adjusted P = .0767) and those of SDC4 with erlotinib ( r = −.434, P = .0826; data not shown).
← all excerpts
Longitudinal Transcriptional Response of Glycosylation-Related Genes, Regulators, and Targets in Cancer Cell Lines Treated With 11 Antitumor Agents.
1
0.0767
0.0767